SCHEMBL6017522

SCHEMBL6017522

CN(C)CC(=O)N1CCCC1COc1ccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2c1

nearest known ligand 0.65

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
EGFR P00533 17/20 0.65
ERBB2 P04626 13/20 0.65
LCK P06239 1/20 0.58
AURKA O14965 1/20 0.51
RPS6KB1 P23443 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5569400 1.00 EGFR (0.65) EGFRERBB2LCKAURKARPS6KB1
SCHEMBL5569118 0.92 ERBB2 (0.76) EGFRERBB2LCKAURKARPS6KB1
SCHEMBL4384983 0.87 ERBB2 (0.85) EGFRERBB2
SCHEMBL5697194 0.87 ERBB2 (0.85) EGFRERBB2
SCHEMBL4387008 0.87 ERBB2 (0.85) EGFRERBB2
SCHEMBL5564723 0.86 EGFR (0.63) EGFRERBB2LCK
SCHEMBL6017201 0.86 EGFR (0.63) EGFRERBB2LCK
SCHEMBL5567889 0.86 EGFR (0.63) EGFRERBB2LCK
SCHEMBL4384872 0.85 ERBB2 (0.81) EGFRERBB2
SCHEMBL5696763 0.85 ERBB2 (0.81) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664028-A1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS AstraZeneca AB (SE) 2006-06-07 EP disclosed
WO-2005026151-A1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2005-03-24 WO disclosed